Susquehanna International Group’s BioVie BIVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-163
Closed -$6.52K 11995
2024
Q2
$6.52K Sell
163
-2,920
-95% -$140K ﹤0.01% 11809
2024
Q1
$163K Buy
3,083
+2,270
+279% +$233K ﹤0.01% 10822
2023
Q4
$102K Buy
813
+615
+311% +$185K ﹤0.01% 11313
2023
Q3
$67.5K Buy
+198
New +$77.4K ﹤0.01% 11149
2023
Q2
Sell
-189
Closed -$153K 12075
2023
Q1
$153K Buy
+189
New +$125K ﹤0.01% 10900

Other funds holding BIVI

Susquehanna International Group's BIVI Position: Q3 2024 in Review

Susquehanna International Group sold out of BioVie (BIVI) in Q3 2024, closing a stake of 246 shares — an estimated $9.85K sold.

Susquehanna International Group first reported a position in BIVI in Q4 2021 and held it in 7 quarters. The position peaked at $1.16M in Q1 2023. 25 funds tracked by Wall St. Rank hold BIVI as of Q3 2024.

  • Susquehanna International Group reported no remaining BioVie position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 246 BioVie shares in Q3 2024, an estimated $9.85K.
  • Susquehanna International Group first reported a position in BioVie in Q4 2021 and held it in 7 quarters.
  • Susquehanna International Group's BioVie position peaked at $1.16M in Q1 2023.
  • 25 funds tracked by Wall St. Rank held BioVie as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.